Subsequently, coupling the antibody against the CYPA biomarker and the color emission of the substrate Tetramethylbenzidine (TMB) permits ovarian cancer detection at low concentrations due to high specificity. The gene discussed is PPIA; the disease is ovarian carcinoma.